Variant report
Variant | nsv553172 |
---|---|
Chromosome Location | chr11:4586873-4592718 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12789853 | chr11:4586873-4586874 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs557653793 | chr11:4586886-4586887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566915512 | chr11:4586890-4586891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571435414 | chr11:4586899-4586900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533818610 | chr11:4586902-4586903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76403586 | chr11:4586925-4586926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187629706 | chr11:4586941-4586942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147863807 | chr11:4586957-4586958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577242039 | chr11:4586976-4586977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76611971 | chr11:4586984-4586985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554117527 | chr11:4586988-4586989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377370562 | chr11:4587005-4587006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193207755 | chr11:4587007-4587008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574024551 | chr11:4587008-4587009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs61883563 | chr11:4587043-4587044 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs141654369 | chr11:4587060-4587061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562032410 | chr11:4587067-4587068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372688406 | chr11:4587073-4587074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529441827 | chr11:4587085-4587086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116821680 | chr11:4587086-4587087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs145441841 | chr11:4587097-4587098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561652155 | chr11:4587127-4587128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78981978 | chr11:4587142-4587143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10836283 | chr11:4587163-4587164 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs567153982 | chr11:4587195-4587196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111637722 | chr11:4587197-4587198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534125646 | chr11:4587204-4587205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371708240 | chr11:4587215-4587216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10836284 | chr11:4587220-4587221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10836285 | chr11:4587224-4587225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146097145 | chr11:4587230-4587231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58444844 | chr11:4587231-4587232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375361300 | chr11:4587232-4587233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11032827 | chr11:4587253-4587254 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs138500119 | chr11:4587261-4587262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564490656 | chr11:4587269-4587270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12278934 | chr11:4587272-4587273 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs11032828 | chr11:4587292-4587293 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs10836286 | chr11:4587303-4587304 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs572345176 | chr11:4587321-4587322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542441906 | chr11:4587339-4587340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561164366 | chr11:4587349-4587350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12278975 | chr11:4587367-4587368 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs10836287 | chr11:4587373-4587374 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs12291768 | chr11:4587405-4587406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531275557 | chr11:4587410-4587411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76282688 | chr11:4587440-4587441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542455004 | chr11:4587447-4587448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374940851 | chr11:4587448-4587449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533980531 | chr11:4587456-4587457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:4586400-4588400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr11:4586600-4588600 | Enhancers | Adipose Nuclei | Adipose |
3 | chr11:4586800-4588600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr11:4590400-4590600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr11:4592400-4593400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr11:4592600-4593600 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr11:4592600-4593600 | Enhancers | H9 Cell Line | embryonic stem cell |